How Important Is Keytruda For Merck? |
August 30, 2019 | August 2019 Bond Updates |
Merck’s (NYSE:MRK) Keytruda is its top selling drug with sales of over $7 billion in 2018. Keytruda is used for the treatment of different types of cancers, including lung, head & neck, and melanoma among others. It has become the most important drug for Merck, given its contribution to the compa... |
View more at: https://www.forbes.com/sites/greatspeculations/2019/08/29/how-important-is-keytruda-for-merck/ |
Related News |
|